Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

GLP‐1 Agonists for Pediatric Psychopharmacology: Opportunities and Cautions

Clinical and Translational Science(2025)10.1111/cts.70262Source: DataRank Database

GLP‐1 Agonists for Pediatric Psychopharmacology: Opportunities and Cautions is a research paper published in Clinical and Translational Science (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.65)OA: goldTopics (37)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Ethan A. Poweleit ORCID,Stephani L. Stancil ORCID,Michael Bartkoski ORCID

Live enrichment

PubMed:40434284 PMC:PMC12117883 OpenAlex:https://openalex.org/W4410821117

NIMH NIH HHS

Grant: K23 MH130728

National Institutes of Health

Grant: 1K23MH130728-01A1

Development of a Pharmacodynamic Biomarker of Opioid Antagonism in Adolescents with Eating Disorders

National Institutes of Health

Grant: 1T32HD069038-01

Childrens Mercy Hospital Fellowship Program in Pediatric Pharmacology

FWCI

1.65

Citation Percentile

0.8%

Citation Trend

2025

2026

goldLicense: cc-by-nc

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.70262

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.70262

publisherhttps://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1111/cts.70262

journalhttps://doi.org/10.1111/cts.70262

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40434284

Fields of Study

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practicesDiabetes Treatment and Management

MeSH Terms

Glucagon-Like Peptide-1 Receptor AgonistsAdolescentFeeding and Eating DisordersChildDiabetes Mellitus, Type 2HumansPsychopharmacologySubstance-Related DisordersGlucagon-Like Peptide 1Pediatric Obesity

Keywords

PsychopharmacologyMedicineAdverse effectDepression (economics)PsychiatryPerspective (graphical)ObesityMental healthPharmacologyInternal medicinePediatric ObesityAdolescentSubstance-Related DisordersRM1-950Feeding and Eating DisordersDiabetes Mellitus, Type 2Glucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like Peptide 1PerspectiveHumansTherapeutics. PharmacologyPublic aspects of medicineRA1-1270Child

Sustainable Development Goals

SDG 0: Good health and well-being

GLP‐1 Agonists for Pediatric Psychopharmacology: Opportunities and Cautions

FAIR Checklist

Authors (3)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)